Li, X., Little, N., Park, H., Foster, C., Chen, Q., & Lu, J. (2021). Tumor-Associated Fibroblast-Targeting Nanoparticles for Enhancing Solid Tumor Therapy: Progress and Challenges. 18(8). https://doi.org/10.1021/acs.molpharmaceut.1c00455

Kamada, H., Martin, J., Slack, M., & Kramer, S. (2021). Understanding the information-seeking behavior of pharmacy college faculty, staff, and students: implications for improving embedded librarian services. 109(2). https://doi.org/10.5195/jmla.2021.950

Whaley, M., Bin Awad, N., Warholak, T., & Axon, D. (2021). Validation Assessment of a Pain Interference Questionnaire among Student Pharmacists. 9(4). https://doi.org/10.3390/pharmacy9040170

Marupuru, S., Dahlmann-Noor, A., Crescioni, M., Slack, M., Barnard, S., Amerat, I., Loveday, A., Chauhan, D., Adler, P., Walker, R., & Warholak, T. (2021). Validity and Reliability of the Student Refractive Error and Eyeglasses Questionnaire-Revised Version in Myopic Children. 98(11). https://doi.org/10.1097/OPX.0000000000001804

Lopez, J., Malacarne, P., Gajos-Draus, A., Ding, X., Daiber, A., Lundberg, J., Offermanns, S., Brandes, R., & Rezende, F. (2021). Vascular biotransformation of organic nitrates is independent of cytochrome P450 monooxygenases. 178(7). https://doi.org/10.1111/bph.15362

Cooley, J., Larson, S., & Stevens, M. (2021). What does experiential education look like in a global pandemic? Reflecting back and looking forward. 13(7). https://doi.org/10.1016/j.cptl.2021.03.017

Svetlov, M., Cohen, S., Alsuhebany, N., Vázquez-Laslop, N., & Mankin, A. (2020). A long-distance rRNA base pair impacts the ability of macrolide antibiotics to kill bacteria. https://doi.org/10.1073/pnas.1918948117

Bingham, J., Almodovar, A., Taylor, A., Axon, D., Nahata, M., Leal, S., Warholak, T., & Scovis, N. (2020). A Research Partnership to Enhance Postgraduate Pharmacy Residency Training Outcomes.

Chinthammit, C., Axon, D., Anderson, E., Lott, B., Taylor, A., Pickering, M., Black, S., Warholak, T., & Campbell, P. (2020). A retrospective cohort study evaluating the relationship between statin medication adherence and economic outcomes in commercial health plans. 14(6). https://doi.org/10.1016/j.jacl.2020.09.005

Muralidharan, P., Mallory, E., Malapit, M., Phan, H., Ledford, J., Hayes, D., & Mansour, H. (2020). Advanced design and development of nanoparticle/microparticle dual-drug combination lactose carrier-free dry powder inhalation aerosols. 10(68). https://doi.org/10.1039/d0ra07203f

Gomez, A., Acosta, M., Muralidharan, P., Yuan, J., Black, S., Hayes, D., & Mansour, H. (2020). Advanced Spray Dried Proliposomes of Amphotericin B Lung Surfactant-Mimic Phospholipid Microparticles/Nanoparticles as Dry Powder Inhalers for Targeted Pulmonary Drug Delivery. https://doi.org/10.1016/j.pupt.2020.101975

Maksimovic, I., Zheng, Q., Trujillo, M., Galligan, J., & David, Y. (2020). An Azidoribose Probe to Track Ketoamine Adducts in Histone Ribose Glycation. https://doi.org/10.1021/jacs.0c01325

Mitchell, J., Berlinski, A., Canisius, S., Cipolla, D., Dolovich, M., Gonda, I., Hochhaus, G., Kadrichu, N., Lyapustina, S., Mansour, H., Darquenne, C., Clark, A., Newhouse, M., Ehrmann, S., Humphries, R., & Boushey, H. (2020). An Urgent Appeal to Clinical Decision-Makers and Governmental Agencies Involved with Public Health to Consider the Potential for Medication Delivery in the Context of COVID-19 Therapies Using the Inhaled Route of Administration. 33(4). https://doi.org/10.1089/jamp.2020.1622

Stevens, M., Howe, C., Ray, A.-M., Washburn, A., Chitre, S., Sivinski, J., Park, H., Hoang, Q., Chapman, E., & Johnson, M. (2020). Analogs of nitrofuran antibiotics are potent GroEL/ES inhibitor pro-drugs. 28(22). https://doi.org/10.1016/j.bmc.2020.115710

Axon, D., Vaffis, S., Chinthammit, C., Lott, B., Taylor, A., Pickering, M., Black, S., Warholak, T., & Campbell, P. (2020). Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications. 26(12). https://doi.org/10.18553/jmcp.2020.26.12.1529

Campbell, P., Axon, D., Taylor, A., Pickering, M., Black, S., Warholak, T., & Chinthammit, C. (2020). Associations of Renin-Angiotensin System Antagonist Medication Adherence and Economic Outcomes Among Commercially Insured US Adults: A Retrospective Cohort Study. 9(17). https://doi.org/10.1161/JAHA.119.016094

Jadala, C., Reddy, S., Krishna, N., Shankaraiah, N., & Kamal, A. (2020). Base-mediated 1,3-dipolar cycloaddition of pyridinium bromides with bromoallyl sulfones: a facile access to indolizine scaffolds. 18(42). https://doi.org/10.1039/d0ob01696a

Ma, C., Sacco, M., Hurst, N., Townsend, J., Hu, S., Szeto, T., Zhang, D., Tarbet, B., Marty, M., Chen, Q., & Wang, L. (2020). Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease. 30(8). https://doi.org/10.1038/s41422-020-0356-z

Schmidlin, C., Zeng, T., Liu, P., Wei, Y., Dodson, M., Chapman, E., & Zhang, D. (2020). Chronic arsenic exposure enhances metastatic potential via NRF2-mediated upregulation of SOX9. 402. https://doi.org/10.1016/j.taap.2020.115138

Karnes, J., Rettie, A., Somogyi, A., Huddart, R., Fohner, A., Formea, C., Lee, J., Llerena, A., Whirl-Carrillo, M., Klein, T., Phillips, E., Mintzer, S., Gaedigk, A., Caudle, K., & Callaghan, J. (2020). Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update. https://doi.org/10.1002/cpt.2008

Acquisto, N., Cushman, J., Rice, A., & Edwards, C. (2020). Collaboration by emergency medicine pharmacists and prehospital services providers. 77(12). https://doi.org/10.1093/ajhp/zxaa082

Hall-Lipsy, E., Anderson, E., Taylor, A., Warholak, T., Axon, D., Faqeeri, Z., & Jastrzab, R. (2020). Community health worker perspectives of an academic community medication therapy management collaboration. 60(3). https://doi.org/10.1016/j.japh.2019.11.018

Nguyen, K., Zhang, D., Roberts, E., Yun, S., McGraw, K., Abraham, I., Song, D., Braswell, D., Qin, D., Sallman, D., Lancet, J., List, A., Moscinski, L., Padron, E., & Zhang, D. (2020). Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated versus acute myeloid leukemia with myelodysplasia-related changes with mutated . 61(6). https://doi.org/10.1080/10428194.2020.1723016

Vadiei, N., & Bhattacharjee, S. (2020). Concurrent Opioid and Benzodiazepine Utilization Patterns and Predictors Among Community-Dwelling Adults in the United States. 71(10). https://doi.org/10.1176/appi.ps.201900446

Woods, D., Vangaveti, S., Egbanum, I., Sweeney, A., Li, X., Bacot-Davis, V., LeSassier, D., Stanger, M., Hardison, G., Li, X., Belfort, M., & Lennon, C. (2020). Conditional DnaB protein splicing is reversibly inhibited by zinc in mycobacteria. 11(4).

Kovalchuk, N., Zhang, D., Van Winkle, L., & Ding, X. (2020). Contribution of Pulmonary CYP-mediated Bioactivation of Naphthalene to Airway Epithelial Injury in the Lung. 177(2). https://doi.org/10.1093/toxsci/kfaa114

Oh, M., Patanwala, A., Alkhatib, N., Almutairi, A., Abraham, I., & Erstad, B. (2020). Cost Analysis of Adjunctive Hydrocortisone Therapy for Septic Shock: U.S. Payer Perspective. 48(10). https://doi.org/10.1097/CCM.0000000000004501

Macdonald, K., McBride, A., AlRawashdh, N., & Abraham, I. (2020). Cost-efficiency and expanded access of prophylaxis for chemotherapy-induced (febrile) neutropenia: economic simulation analysis for the US of conversion from reference pegfilgrastim to biosimilar pegfilgrastim-cbqv. 23(12). https://doi.org/10.1080/13696998.2020.1833339

Axon, D., Chinthammit, C., Tate, J., Taylor, A., Leal, S., Pickering, M., Black, S., Warholak, T., & Campbell, P. (2020). Current Procedural Terminology Codes for Medication Therapy Management in Administrative Data. 26(10). https://doi.org/10.18553/jmcp.2020.26.10.1297

Muralidharan, P., Jones, B., Allaway, G., Biswal, S., & Mansour, H. (2020). Design and development of innovative microparticulate/nanoparticulate inhalable dry powders of a novel synthetic trifluorinated chalcone derivative and Nrf2 agonist. 10(1). https://doi.org/10.1038/s41598-020-76585-2